JIPMER Announces Conduction Of 9th CNE Workshop Based On Short Term Courses For Nurses

Puducherry: Jawaharlal Institute of Postgraduate Medical Education & Research (JIPMER) has announced the conduction of the 9th CNE Workshop Based Short Term Course on Research Methodology & Publication for Nurses.

As per the notice, the CNE Workshop will be conducted from 29.01.2024 to 04.02.2024 at Multipurpose Hall, College of Nursing, JIPMER. The Workshop is funded by the Ministry of Health & Family Welfare, Government of India and organized by the College of Nursing, JIPMER, Puducherry. The Tamil Nadu Nurses & Midwives Council, Chennai will award credit hours.

Only 30 participants can participate. Registration confirmation is based on a First come, first served basis. No registration fee is to be paid. The link for registration is enclosed in the notice below. The participants will have to fill out a Google form. TA Rs.500 for 7 days with the submission of documents and whichever is minimum, DA Rs.300/day, Lunch and refreshments will be arranged as per MOHFW (Nursing section) norms. Accommodation needs to be arranged by the participants.

Also Read:Laurels to Dept of nursing Services of JIPMER at SINNCON 2023

The detailed schedule related to the Workshop –

Day 1 – 29.01.2024 – Monday – 

Time

Session

Duration

Resource person/ Guest Speaker

09.00 a.m. – 09.30 a.m.

Registration & Pretest

30 min

Dr. M. J. Kumari

09.30
a.m. –

09.45
a.m.

Inauguration

15 min

–

09.45 a.m. – 10.15 a.m.

Overview of
nursing research –

How to
choose the research problem Steps for formulating research problems
Discussion using examples

30 min

Mr. R. S. Ramesh

10.15
a.m. –

10.30
a.m.

Tea break

15 min

–

10.30
a.m. –

11.15
p.m.

How to
frame the research question, objective Group activity with exercises &
presentation

45 min

Mrs. Vembu.K

11.15
p.m. –

12.00
p.m.

How to
frame the hypothesis and assumption Group activity with exercises &
presentation

45 min

Mrs. Yamuna. T.V.

12.00 p.m. – 01.00 p.m.

Variables
and different types of variables Group activity with discussion

60 min

Dr.KT.Harichandra
kumar

01.00 p.m. – 02.00 p.m.

Lunch break

60 min

–

02.00 p.m. – 02.45 p.m.

How to
search the review of literature, Boolean Operators, Filtering, MESH terms
with demo

45 min

Mrs.
Gomathi Arumugam

02.45 p.m. – 03.30 p.m.

Observational,
descriptive & analytical study Group activity with exercises &
presentation

45 min

Dr. Jeeva
Subramaniam

03.30 p.m. – 04.30 p.m.

COHORT and
Case Control study Group activity with exercises & presentation

60 min

Dr. Sonali Sarkar

Day 2 – 30.01.2024 – Tuesday – 

Time

Session

Duration

Resource person/ Guest Speaker

09.00 a.m. – 10.00 a.m.

Experimental
research design and Randomized controlled trial (RCT) registration with demo
Group activity with exercises & presentation

60 min

Dr. Lakshmi
Ramamoorthy

10.00
a.m. –

11.00
a.m.

Quasi
experimental study with case scenario discussion

60 min

Dr. Jeeva
Subramaniam

11.00
a.m. –

11.15
a.m.

Tea break

15 min

–

11.15
a.m. –

12.15
p.m.

Qualitative studies

Group activity with exercises &
presentation

60 min

Mrs.
Gomathi Arumugam

12.15 p.m. – 01.15 p.m.

Mixed
method research design – Sequential Explanatory, Exploratory &
Transformative Design, Discussion with scenario

60 min

Dr. Porkodi
Rabindran

01.15 p.m. – 02.15 p.m.

Lunch break

60 min

–

02.15 p.m. – 03.15 p.m.

Mixed
method research design – Concurrent Triangulation, Embedded & Transformative
Design, Discussion with scenario

60 min

Mrs. Aruna. P

03.15 p.m. – 04.30 p.m.

Probability
& Non probability sampling technique with exercise, Group activity

75 min

Dr. Jayalakshmy R

Day 3 – 31.01.2024 – Wednesday – 

Time

Session

Duration

Resource person/ Guest Speaker

09.00 a.m.
– 10.00 a.m.

Data,
data types and data summarization

60 min

Dr. G. Prabavathy

10.00 a.m. –

11.00 a.m.

Tabular
and graphical representation of data

60 min

Mrs. R. Anusuya

11.00 a.m. –

11.15 a.m.

Tea break

15 min

–

11.15 a.m. –

12.15 p.m.

Steps in developing questionnaire/ interview schedule

Group activity with exercises

60 min

Dr. Jeeva
Subramaniam

12.15 p.m.
– 01.15 p.m.

Steps in developing observation schedule/ checklist

How to check the reliability & validity of the tool
Group activity with exercises

60 min

Dr. Mahalakshmy T

01.15 p.m.
– 02.15 p.m.

Lunch
break

60 min

–

02.15 p.m.
– 03.15 p.m.

Administration of tool to the study participants –
Discussion with example

60 min

Mrs.
Gomathi Arumugam

03.15 p.m.
– 04.30 p.m.

Techniques of data collection with case scenario discussion

75 min

Dr. Malarvizhi.S

Day 4 – 01.02.2024 – Thursday – 

Time

Session

Duration

Resource person/ Guest Speaker

09.00 a.m. – 10.15 a.m.

Data
collection interview method with role play

75 min

Dr. Selvambigai. V.R

10.15
a.m. –

11.30
a.m.

Research
Bias and how to control the bias Study based discussion

75 min

Ms.H.T.Lalthanthuami

11.30
a.m. –

11.45
a.m.

Tea break

15 min

–

11.45 a.m. – 01.00 p.m.

Introduction
to ethics in human studies ICMR guidelines for responsible conduct of
research

75 min

Dr. Rema Devi

01.00 p.m. – 02.00 p.m.

Lunch break

60 min

–

02.00 p.m. – 03.15 p.m.

IEC members
& IEC committee responsibilities

75 min

Dr. Rajeswari. R

03.15 p.m. – 04.30 p.m.

Level of
risk for human studies with case scenario discussion

75 min

Mrs. Kanimozhi. K

Day 5 – 02.02.2024 – Friday – 

Time

Session

Duration

Resource person/ Guest Speaker

09.00 a.m. – 10.00 a.m.

Health
research on vulnerable population with case scenario discussion

60 min

Dr. Janarthanan.B

10.00
a.m. –

11.00
a.m.

Different
types of Informed consent and patient information

60 min

Dr. K. Sivasankari

11.00
a.m. –

11.15
a.m.

Tea break

15 min

–

11.15
a.m. –

12.15
p.m.

Informed consent for special/ vulnerable
group

60 min

Dr. Vetriselvi. P

12.15 p.m. – 01.15 p.m.

Conflict of
interest with case scenario discussion

60 min

Mrs. Vembu. K

01.15 p.m. – 02.15 p.m.

Lunch break

60 min

–

02.15 p.m. – 03.15 p.m.

Grant
writing for intramural and extramural fund with various source of funding

60 min

Dr. S.
Suresh Kumar

03.15 p.m. – 04.30 p.m.

Checking plagiarism &

Grammar check with demo

75 min

Dr. Noyal
Mariya Joseph

Day 6 – 03.02.2024 – Saturday – 

Time

Session

Duration

Resource person/ Guest Speaker

09.00 a.m. – 10.00 a.m.

Introduction to statistical
inference

60 min

Dr KT.
Harichandra Kumar

10.00
a.m. –

11.00
a.m.

Sample size for descriptive studies

60 min

Dr. G. Prabavathy

11.00
a.m. –

11.15
a.m.

Tea break

15 min

–

11.15
a.m. –

12.15
p.m.

Sample size for analytical studies

60 min

Dr.
KT.Harichandra Kumar

12.15 p.m. – 01.15 p.m.

Publication ethics with case
scenario discussion

60 min

Dr.
Nivethitha Kandasamy

01.15 p.m. – 02.15 p.m.

Lunch break

60 min

–

02.15 p.m. – 03.15 p.m.

Research manuscript
writing for scientific paper publication with group discussion

60 min

Dr. M. J. Kumari

03.15 p.m. – 04.30 p.m.

How to
choose the journal for publication to increase the visibility of publication
with group discussion

75 min

Dr. Subitha.L

Day 7 – 04.02.2024 – Sunday – 

Time

Session

Duration

Resource person/ Guest Speaker

09.00 a.m. – 10.15 a.m.

Different tests of statistical
significance

75 min

Dr. KT
Harichandra Kumar

10.15
a.m. –

11.00
a.m.

How to
prepare the manuscript for poster and oral presentation in conference
discussion with example

45 min

Mrs. Vidya. J

11.00
a.m. –

11.15
a.m.

Tea break

15 min

–

11.15
a.m. –

12.15
p.m.

How to
implement the research findings and practice with case based discussion

60 min

Dr. Kavitha. R.R

12.15 p.m. – 01.15 p.m.

How to
write the research protocol and reference with Demo

60 min

Mrs. S. Rani

01.15 p.m. – 02.15 p.m.

Lunch break

60 min

–

02.15 p.m. – 03.15 p.m.

How to
write the various source of reference Group activity and presentation

60 min

Mrs. S. Rani

03.15 p.m. – 04.30 p.m.

Posttest and valedictory

75 min

Dr. M. J. Kumari

To view the notice, click on the link below –

https://medicaldialogues.in/pdf_upload/brochure-27122023-229067.pdf

Also Read:JIPMER Announces Conduction Of 1st Year Orientation Program For MD, MS, DM, MCH, MDS students

Powered by WPeMatico

Smoking affects brain volume finds a new study

Smoking among the young has increased drastically among the younger population and this habit is often related to lung and heart problems but its association with brain was not well known.

Several studies have shown that brain volume is negatively associated with cigarette smoking, but there is an ongoing debate about whether smoking causes lowered brain volume or a lower brain volume is a risk factor for smoking.

A study carried out by scientists at the University of Washington, United States, showed that smoking also affects the brain, being related to the appearance of Alzheimer’s and dementia, a specialized magazine published. 

Researchers looked at the consequences of tobacco use at the brain level, and their findings help explain why smokers are at high risk of age-related cognitive decline and Alzheimer’s disease, according to an article in Biological Psychiatry: Global Open Science. A history of daily smoking is strongly associated with a decreased total brain volume.

With the aim of unraveling the relationship between genetics, brain and behavior, the authors of the research analyzed data extracted from the UK Biobank, on the health and behavior of half a million people, mostly of European descent.

The team analyzed de-identified data on brain volume, smoking history and genetic risk of smoking from 32,094 people.

They were able to show that each pair of factors were related: smoking history and brain volume; genetic risk of smoking and history of smoking; and genetic risk of smoking and brain volume. Furthermore, the association between smoking and brain volume was dose-dependent: the more packs a person smoked per day, the smaller their brain volume.

When all three factors were considered together, the association between genetic risk for smoking and brain volume disappeared, while the link between each of them and smoking behaviors remained.

Using a statistical approach known as mediation analysis, the researchers determined the sequence of events: genetic predisposition leads to smoking, which leads to a decrease in brain volume.

Reference: Yoonhoo Chang, Vera Thornton, Ariya Chaloemtoem et al; Investigating the Relationship Between Smoking Behavior and Global Brain Volume; Biological Psychiatry: Global Open Science, | VOLUME 4, ISSUE 1, P74-82, JANUARY 2024.

Powered by WPeMatico

MUHS to hold its 23rd Convocation Ceremony in February, all details here

Maharashtra: The 23rd convocation ceremony of Maharashtra University of Health Sciences (MUHS) is going to be held on 23rd February 2023 for various UG and PG courses.

The candidates will have to fill out the application form for the ceremony. Printed application forms will not be available offline. Eligible candidates will have to download the application form and take a printout of it. The application form is enclosed in the notice below. Application, duly completed in all respects, should reach the Controller of Examinations on or before 05.01.2024. If the application form is received after this date, the Degree Certificate / Diploma Certificate will be issued after the Convocation Ceremony as per due procedure.

It is further informed that those candidates who fail to submit their application within the stipulated time period and applications received at a later date will attract late fee charges mentioned in the University Circular dated 21.03.2014.

Also Read:CPS announces Convocation Ceremony For Diploma, FCPS Students

Successful candidates of the following courses will be awarded the degree certificates/certificates in this convocation ceremony –

Course

Batch and Year

MBBS

Summer 2022

BDS

Summer 2022

BAMS

Summer 2022

BUMS

Summer 2022

BHMS

Summer 2022

Basic BSc (Nursing)

Summer 2023

PBBSc (Nursing)

Summer 2023

BSc in Paramedical Technology

Summer 2022

MD (Medical)

Summer 2023 & Winter 2023

MS (Medical)

Summer 2023 & Winter 2023

DM (Medical)

Summer 2023 & Winter 2023

MCh (Medical)

Summer 2023 8v Winter 2023

MSc (Medical Biochemistry)

Summer 2023 & Winter 2023

PG Diploma (All)

Summer 2023

Diploma in Optometry

Summer 2023

Bachelor of Optometry

Summer 2022

Diploma in Para Medical

Summer 2023

MDS (Dental)

Summer 2023

MD (Ayurveda)

Summer 2023

MS (Ayurveda)

Summer 2023

Course

Batch and Year

MD (Unani)

Summer 2023

MS (Unani)

Summer 2023

MD (Homoeopathy)

Summer 2023

MSc (Nursing)

Summer 2023

MBA

Summer 2023 & Winter 2023

MPH (N)

Summer 2023 & Winter 2023

MPH

Winter 2023

PhD

After the date of Mini Convocation-2023 & results
declared before the date of Convocation

All Certificate / Fellowship Courses

Summer 2023

Students of earlier courses and batches covered during the last,
i.e. 22″d convocation ceremony, can apply only in absentia. Degree
Certificates / Diploma Certificates of all the candidates who opt to receive
their Degree Certificates / Diploma Certificates in absentia will be sent to
their respective colleges. However, students covered under the above-mentioned
courses can apply for receiving the Degree Certificate / Diploma Certificate
either in person or in abseatia. No change in the mode of receipt of Degree
Certificate / Diploma Certificates will be permitted once opted.

To view the notice, click on the link below –

https://medicaldialogues.in/pdf_upload/examcircular-no90convocation-281223-1-229048.pdf

Also Read:WBUHS opens University online registration portal For MSc Nursing, Post Basic BSc Nursing Courses

Powered by WPeMatico

WBCERC has no authority to adjudicate medical negligence cases: Calcutta HC

In a major decision, the Calcutta High Court bench has clearly iterated that matters concerning the issues of medical negligence cannot be adjudicated by the West Bengal Clinical Establishment Regulatory Commission (WBCERC).

Clarifying its stand in this regard, the HC bench comprising Justice Arijit Banerjee and Justice Apurba Sinha Ray noted, “The negligence in detection of diseases and the allegation of not giving proper medicines to the patient and further improper diagnosis of the diseases are all matters or issues of medical negligence. Therefore, the said issues cannot be adjudicated by the Commission.”

For more details, check out the link given below:

WBCERC Has No Authority To Adjudicate Medical Negligence Cases: Calcutta High Court

Powered by WPeMatico

Conduct BE study with innovator drug as reference product: CDSCO Panel Tells Synokem on FDC Torsemide plus Eplerenone

New Delhi: After reviewing the bioequivalence (BE) study report presented by Synokem Pharmaceutical for the fixed-dose combination Torsemide IP 10mg/20mg plus Eplerenone IP 25mg/25mg film-coated tablet, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has recommended that the firm should conduct BE study with individual innovator drugs as a reference product and submit the BE protocol to the committee.

This came after Synokem Pharmaceutical presented its proposal and a BE study report before the committee.

The committee noted that the firm has not conducted the BE study with individual innovator drugs as a reference product.

Torsemide belongs to the group of medicines called loop diuretics (water pills). This medicine works by acting on the kidneys to increase the flow of urine. Torsemide is used to help treat fluid retention (edema) and swelling that is caused by congestive heart failure, liver disease, and kidney disease. It belongs to the group of medicines called loop diuretics (water pills). This medicine works by acting on the kidneys to increase the flow of urine.

Eplerenone belongs to the general class of medicines called antihypertensives. It is used alone or with other medicines to treat high blood pressure (hypertension). This medicine is also used to treat congestive heart failure (CHF) after a heart attack.

Eplerenone selectively binds to the mineralocorticoid receptor, thereby blocking the binding of aldosterone and thus inhibiting sodium reabsorption and other deleterious aldosterone-mediated mechanisms.

At the SEC meeting for Cardiovascular and Renal held on 22nd November 2023, the expert panel reviewed the proposal presented by the drug major Synokem Pharmaceutical along with the BE study report of the FDC Torsemide plus Eplerenone film coated table.

The committee took note of the fact that the company had not used specific innovative medications as a reference product in the BE study.

After detailed deliberation, the committee recommended that the firm should conduct a BE study with individual innovator drugs as a reference product.

Accordingly, the expert panel suggested that the firm should submit the BE protocol to CDSCO for further review.

Also Read:Include Ankle Brachial Index test to exclude peripheral artery disease: CDSCO Panel Tells Lupin on Denosumab PK/PD study

Powered by WPeMatico

Amendments to MTP Act soon: Delhi LG VK Saxena

New Delhi: After a two-year delay, the proposal to notify women-friendly amendments in the Medical Termination of Pregnancy (MTP) Act that provides for universal access for women to comprehensive abortion care has been approved by Lieutenant Governor V K Saxena.

LG V K Saxena has directed the health department to investigate the lapses that led to delays in the processing of the matter.

Delhi will soon notify women-friendly amendments to the Medical Termination of Pregnancy Act, with Lieutenant Governor V K Saxena approving the city government’s proposal in this regard, Raj Niwas officials said on Thursday.  

However, Saxena expressed “grave displeasure” and “surprise” that the matter was presented for approval after a lapse of more than two years, they added.

Also Read:U Turn: SC recalls Order calling for MTP at 26 weeks

“The LG has approved the proposal of the Delhi government’s Department of Health and Family Welfare for issuance of notification regarding the statutory forms under the Medical Termination of Pregnancy (Amendment) Act, 2021 that provide for universal access for women to comprehensive abortion care and termination of certain pregnancies by registered medical practitioners (RMPs),” an official said.

The communication for notifying the Act was mailed by the Centre to the Delhi government in December 2021, he added.

Saxena directed the health department to ascertain the lapses leading to the “inordinate delay” in processing the matter and asked to assign the responsibility and exercise caution in the future, the official said.

The Act was amended by the Centre in 2021, after which the opinion of only one RMP is required up to 20 weeks of gestation and of two RMPs to terminate pregnancy of 20-24 weeks of gestation under special circumstances. The amended Act provided for the constitution of a medical board for granting permission to terminate pregnancy beyond 24 weeks under circumstances to be decided by it.

The Ministry of Health and Family Welfare conveyed in 2021 that the forms for the documentation of medical termination of pregnancy (which were earlier issued in terms of the MTP Act, 1971) were updated in consonance with the Medical Termination of Pregnancy (Amendment) Act and Rules, 2021.

The ministry had directed the states and Union territories to notify Forms 1, 2 and 3 in the official gazette under the MTP Regulations, the official explained.

The amendments carried out in Form 1 (RMP Opinion Form) require the name, qualifications and address of only one RMP and the words “married woman” have been replaced with “woman” and the word “husband” has been replaced with “partner”.

In Form 2, which stipulates the regulations, three additional sub-heads regarding the duration of pregnancy have been added, and the reasons for termination of pregnancy have been divided into A, B and C categories, depending on the number of weeks of gestation.

Form 3 concerns the admission register in which a phrase has been added for pregnancy beyond 24 weeks and which says that the names of the medical board members have to be mentioned.

The LG was informed that the Department of Health and Family Welfare’s proposal regarding the notification of the statutory forms has been endorsed by the health minister and approved by the chief minister.

Also Read:Delhi HC directs LNJP Hospital to examine pregnant woman seeking termination of 33-week fetus

Powered by WPeMatico

Delhi Health Minister takes stock of LNJP hospital COVID preparedness

Delhi Health Minister Saurabh Bharadwaj visited the LNJP Hospital on Thursday to take stock of its preparedness for COVID-19 and asserted that the facility is fully geared to deal with any exigencies.

Bharadwaj told PTI Video that arrangements for conducting RT-PCR tests have been made outside the hospital and there is modern equipment at the health facility. He said no Covid patient is admitted in the hospital at present.

For more details, check out the link given below:

Delhi Health Minister Visits LNJP Hospital, Takes Stock Of Covid Preparedness

Powered by WPeMatico

Submit PSUR data: CDSCO Panel Tells Shilpa on additional indication of Rheumatoid Arthritis drug Adalimumab

New Delhi: In response to the proposal presented by the drug major Shilpa for the extrapolation of indications for Adalimumab 100mg/mL approved in India for the indication of Rheumatoid Arthritis (RA) in adult patients, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has recommended the firm to submit periodic safety update report (PSUR) data for the first six months for consideration of approval for the additional indications.

This came after the firm presented the proposal for extrapolation of indications in line with the innovator-approved indications for Adalimumab 100mg/mL approved in India for the indication of Rheumatoid Arthritis (RA) in adult patients.

The committee noted that the firm has recently launched the drug product in the market and has not yet submitted the first PSUR.

Adalimumab injection products are in a class of medications called tumor necrosis factor (TNF) inhibitors. They work by blocking the action of TNF, a substance in the body that causes inflammation.

Adalimumab is a type of drug known as a biological therapy. In rheumatoid arthritis and some other conditions, too much of a protein called TNF is produced in the body. This causes inflammation, pain, and damage to your joints.

Adalimumab is the first fully human recombinant immunoglobulin G1 monoclonal antibody that binds and neutralizes soluble and membrane-bound tumor necrosis factor (TNF) so that it cannot interact with p55 and p75 cell-surface TNF receptors.

At the recent SEC meeting for analgesic and rheumatology held on 8th and 9th November 2023, the expert panel reviewed the proposal for extrapolation of indications in line with the innovator-approved indications for Adalimumab 100mg/mL approved in India for the indication of Rheumatoid Arthritis (RA) in adult patients presented by drug major Shilpa.

After detailed deliberation, the committee recommended that the firm should submit PSUR data for the first six months for consideration of approval for the additional indications.

Also Read:Ajanta Pharma Gets CDSCO Panel Nod To Study Antihypertensive FDC

Powered by WPeMatico

MKCG Anaesthesiologist held for allegedly using fake caste certificate

Bhubaneswar: In a shocking incident, an assistant professor working in the department of anesthesiology at MKCG Medical College and Hospital in Berhampur has been arrested for allegedly producing a fake caste certificate to pursue his medical studies at the institute as well as securing his present job.  

The accused doctor is an assistant professor of the Department of Anaesthesia at MKCG. He is a resident of Samabaya Colony in the Semiliguda area of the tribal-dominated Koraput district.

The doctor’s arrest on Wednesday shed light on the incident, which was brought to attention following a case filed by his younger brother on July 20, 2023.

Also read- Kolkata Doctor Arrested For Allegedly Raping, Holding18-Year-Old Nurse Captive

The complainant had accused that the doctor who originally belongs to the Brahmin caste, studied till graduation in arts streams as a general category student. He also pursued a D Pharma course at a college in Bhubaneswar under the general category with his original identity, IANS reports.

According to the complaint, the doctor allegedly secured a fake certificate identifying himself as an Adivasi. He reportedly got admitted to the MBBS course in 2006 and a three-year specialisation course in 2014 at the MKCG medical college using a fake caste certificate.

He has reportedly been working as an assistant professor in the anaesthesiology department of the medical college since 2021.

According to an Odishatv news report, the doctor secured a job using his fake caste certificate at MKCG Medical College in 2017. After serving 5 years in the institute, the doctor got a promotion in 2022. It has emerged that the doctor had been using two surnames- ‘Jani’ and ‘Sasani’ for a long time.

“In 2003, the accused managed to get a false caste certificate under the surname Jani by showing himself as the son of a person in Mandarguda village belonging to a scheduled tribe,” said a local police official.

The police officials claimed that the accused later studied Class-X through distance education, +2 regular course in science stream at the BJB College in Bhubaneswar producing the fake certificate.

Subsequently, a case was registered against the doctor under IPC sections 468, 471, 420, and 506 and he was arrested. An investigation into the case is underway. 

Also read- Woman’s Eyes Go Missing After Post-Mortem: Two Doctors Arrested

Powered by WPeMatico

NBE notifies on selective, final edit window for FMGE December 2023 applications

Through a recent notice, the National Board of Examinations (NBE) has notified about the selective and final edit window for applicants of the Foreign Medical Graduate Examination (FMGE) December 2023. The list of candidates who need to correct the images in their applications has also been released.

Pursuant to the closure of the edit window on 18.12.2023, it has been noted that some candidates have not uploaded their photographs, signatures, and/or thumb impressions as per the prescribed Image Upload Instructions. Such candidates are required to rectify the image(s) in their application form during the selective and final edit window.

For more details, check out the link given below:

NBE Notifies On Selective, Final Edit Window For FMGE December 2023 Applications, All Details Here

Powered by WPeMatico